Read the full report before you order
Specifically, due to the multi-use nature of technological items and devices, we proposed at 512.770(b)(1) and (2) the following stipulations for technology that are provided to ASM beneficiaries: Items or services involving technology provided to a ASM beneficiary must be the minimum necessary to advance a clinical goal of the model as proposed at 512.770(b), which are: promoting preventive care through improved management of ASM targeted chronic conditions
Chia CW, Carlson OD, Kim W, Shin YK, Charles CP, Kim HS, Melvin DL, Egan JM: Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes
It works by slowing gastric emptying, stimulating insulin release in response to food, and signaling the brain's satiety centers to reduce hunger
After 18 hours, cells were labelled with 10 nM JFX646 Halo ligand (kind gift from the Lavis lab, Janelia) in optiMEM (Gibco) for 3 minutes, followed by 3 washes in mKRB buffer (140 mM NaCl, 2.8 mM KCl, 2 mM MgCl 2 , 1 mM CaCl 2 , 10 mM HEPES, 10 mM glucose, pH 7.4) at 37 C
[24] Soon after investigation began into its ability to modulate satiety and appetite
